A Phase IV Study of Huazhi Rougan Granule

Clinical trial NCT06188611 · COMPLETED

Trial details

NCT number: NCT06188611
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Start date: 2017-05-18
Primary completion: 2018-11-08
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.